DexCom, Inc.
DXCM
#760
Rank
$33.570 B
Marketcap
United States
Country
$88.96
Share price
-0.64%
Change (1 day)
12.04%
Change (1 year)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing…
Key Metrics
Trailing P/E
33.47
Forward P/E
27.11
EPS (TTM)
$2.53
Forward EPS
$3.12
Price / Book
12.19
EV / EBITDA
22.4x
Beta
1.42
Dividend Yield
—
Return on Equity
38.49%
Return on Assets
10.33%
Debt / Equity
53.35
Current Ratio
1.73
Gross Margin
62.47%
Operating Margin
24.33%
Net Profit Margin
20.12%
Free Cash Flow
$1.021B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 17 – Sep 14
-4.60%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$4.662B
Latest Net Income$836.300M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare DexCom, Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
DXCM
No recent news available. Set FINNHUB_API_KEY to enable news.
